Title:
NEW APPLICATIONS OF Β3 ADRENERGIC RECEPTOR AGONIST
Document Type and Number:
WIPO Patent Application WO/2013/113141
Kind Code:
A1
Abstract:
Disclosed are new applications of the β3 adrenergic receptor agonist. The β3 adrenergic receptor agonist is an important factor for regulating and controlling SIRT1, mTOR, and p53. The β3 adrenergic receptor agonist can be used for preparing medicine for treating diseases related to signaling pathways such as SIRT1, mTOR, and p53, for example, treating the diseases such as malignancy, hypertrophic cardiomyopathy, pulmonary hypertension, cirrhosis, rheumatoid arthritis, renal failure, and Alzheimer's disease.
Inventors:
LIN SHUGUANG (CN)
ZHENG MENG (CN)
ZHENG MENG (CN)
Application Number:
PCT/CN2012/070767
Publication Date:
August 08, 2013
Filing Date:
January 30, 2012
Export Citation:
Assignee:
LIN SHUGUANG (CN)
ZHENG MENG (CN)
ZHENG MENG (CN)
International Classes:
A61K31/192; A61P1/16; A61P9/00; A61P9/10; A61P9/12; A61P11/00; A61P13/12; A61P25/28; A61P35/00; A61P35/02; A61P43/00
Foreign References:
| CN1751019A | 2006-03-22 |
Other References:
YANG MING ET AL.: "Research progress of relationships between adrenergic beta-3-receptor and heart failure.", CONTEMPORARY MEDICINE, 2007, pages 31 - 32
Attorney, Agent or Firm:
YOGO PATENT & TRADE MARK AGENCY LIMITED COMPANY (CN)
广州粤高专利商标代理有限公司 (CN)
广州粤高专利商标代理有限公司 (CN)
Download PDF:
Claims: